phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide has been researched along with xanthenes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianchi, E; Ghelardini, C; Norcini, M; Smrcka, A | 1 |
1 other study(ies) available for phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide and xanthenes
| Article | Year |
|---|---|
Supraspinal Gbetagamma-dependent stimulation of PLCbeta originating from G inhibitory protein-mu opioid receptor-coupling is necessary for morphine induced acute hyperalgesia.
Topics: Animals; Cyclohexanes; Disease Models, Animal; Drug Administration Routes; Drug Interactions; Exploratory Behavior; Gene Expression Regulation; GTP-Binding Protein beta Subunits; Hyperalgesia; Immunoprecipitation; Male; Mice; Mice, Knockout; Morphine; Pain Measurement; Pain Threshold; Periaqueductal Gray; Phospholipase C beta; Reaction Time; Receptors, Opioid, mu; Somatostatin; Xanthenes | 2009 |